2 Winning Growth Stocks That Are Screaming Buys Right Now
The company has been doing incredibly well, and revenue as well as profits have skyrocketed in recent quarters. Shares of ...
Fiona Bruce's infuriating BBC Question Time habit leaves fans making same demand
BBC Question Time fans called for presenter Fiona Bruce to be "sacked" by the broadcasters as a habit of hers infuriated them ...
Dear Abby: Not to be a grinch, but this person’s presence will ruin the holiday concert
Dear Abby is written by Abigail Van Buren, also known as Jeanne Phillips, and was founded by her mother, Pauline Phillips.
Fox 415h
CAUGHT IN THE ACT: Cape Coral woman arrested for trying to sell boat that wasn't hers
Fox 4's Austin Schargorodski reports on a Cape Coral woman arrested for trying to sell a boat that wasn’t hers, using forged ...
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...
3-Stock Lunch: Nvidia, Levi Strauss & Co & Hims & Hers Health Inc
Fox News' Bryan Llenas reports from the picket line at Red Hook Terminal in New York on the union's demands and impact of the ...
For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away
Hims & Hers shares tanked after regulators signaled new limits on the production of versions of weight-loss drugs.
Is Hims & Hers rally at risk as GLP-1 shortages ease?
Hims & Hers' (HIMS) stock drop marks the latest overhang on a company that has more than doubled in value over the past 12 ...
Hims & Hers Health Stock Falls as FDA Drops Eli Lilly Weight-Loss Drugs From Shortage List
Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration said Eli Lilly's popular weight-loss drugs ...
Zepbound is no longer in shortage. That could hurt off-brand weight loss drug sellers
The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food ...
Lilly weight-loss drug copycats dealt blow as shortage ends
Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., ...
Lilly's weight-loss, diabetes drugs no longer in shortage, pressuring Hims and Hers' stock
The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage, signaling that the company has succeeded in expanding ...